HomeVVY • AMS
add
Vivoryon Therapeutics NV
Previous close
€1.78
Day range
€1.76 - €1.78
Year range
€0.65 - €6.30
Market cap
46.24M EUR
Avg Volume
60.18K
P/E ratio
-
Dividend yield
-
Primary exchange
AMS
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.58M | -50.48% |
Net income | -3.50M | 60.23% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.53M | 59.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.43M | -67.02% |
Total assets | 11.28M | -63.40% |
Total liabilities | 3.40M | -25.14% |
Total equity | 7.88M | — |
Shares outstanding | 26.07M | — |
Price to book | 5.95 | — |
Return on assets | -79.26% | — |
Return on capital | -112.05% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.50M | 60.23% |
Cash from operations | -2.94M | -366.93% |
Cash from investing | -1.00K | 99.98% |
Cash from financing | -14.50K | -103.83% |
Net change in cash | -2.95M | 46.40% |
Free cash flow | -1.74M | 64.36% |
About
Founded
1997
Website
Employees
15
